Cancer News and Research

Latest Cancer News and Research

Initial insight into sedentary behavior counseling practices in primary care settings

Although primary care physicians take care of many aspects of health and disease, little is known about how they can change sedentary behavior through counseling, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

23 Oct 2012

Full-body exercise and CDT best ways to minimize lymphedema

Nearly 40 percent of breast cancer survivors suffer from lymphedema, a chronic condition that causes body limbs to swell from fluid buildup, as a result of lymph node removal and radiation therapy.

23 Oct 2012

Highlights of colorectal cancer research from ACG annual scientific meeting

Women under age 50 who have been diagnosed with endometrial cancer, and first, second and third degree relatives of patients with colorectal cancer may have an increased risk of developing colorectal cancer (CRC), according to two separate studies unveiled today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas.

23 Oct 2012

SLU medical students to raise awareness about teen suicide among tech savvy millennials

Two Saint Louis University medical students are taking the multimedia route to raise awareness about teen suicide among tech savvy millennials.

23 Oct 2012

Austrian researchers receive $7.4 million award to verify new breast cancer pathways

The innovator's award recognises Josef Penninger's work in identifying a key molecular pathway how hormone replacement therapies and contraceptive pills can lead to breast cancer. His team provided the first genetic proof that a protein called RANKL is the master regulator of bone loss, which has contributed to the development of a novel drug already approved for the treatment of osteoporosis and skeletal related events in multiple cancers.

23 Oct 2012

Abbott announces results from HUMIRA clinical studies on ulcerative colitis

Abbott (NYSE: ABT) today announced results from an analysis of three-year long-term data from an ongoing open-label extension of the HUMIRA (adalimumab) ULTRA 1 and ULTRA 2 studies.

23 Oct 2012

In the campaign's home stretch, presidential candidates launch new ads on Medicare, women's health issues

President Barack Obama and GOP presidential hopeful Mitt Romney continue to fight for women's votes, which are considered key to winning the election.

23 Oct 2012

Protective association between statin use and esophageal cancer

Statins, a cholesterol lowering drug may lower the risk of esophageal cancer, especially in patients with Barrett's esophagus, Mayo Clinic researchers report in a study being presented at the American College of Gastroenterology annual meeting.

23 Oct 2012

First Edition: October 23, 2012

Today's headlines include various reports from the campaign trail as well as the latest news about current meningitis outbreak.

23 Oct 2012

Patients with Type 2 Diabetes may face increased risk of Barrett's Esophagus

Patients with Type 2 Diabetes may face an increased risk for Barrett's Esophagus (BE), regardless of other risk factors including smoking, alcohol consumption, obesity and gastroesophageal reflux disease (GERD), according to research unveiled today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas.

23 Oct 2012

Breast cancer spread dependent on both environment and genetic changes

A new study from Johns Hopkins researchers suggests that the lethal spread of breast cancer is as dependent on a tumor’s protein-rich environment as on genetic changes inside tumor cells.

23 Oct 2012

Exercise may protect the brain from age-related changes

People who exercise later in life may better protect their brain from age-related changes than those who do not, a study suggests.

23 Oct 2012

Interim results from CEL-SCI's Multikine Phase III study on head and neck cancer

CEL-SCI Corporation announced today that an interim review of the safety data from its open label, randomized, controlled, pivotal Phase III study of Multikine (Leukocyte Interleukin, Injection) investigational immunotherapy by an Independent Data Monitoring Committee (IDMC) raised no safety concerns.

23 Oct 2012

Glioblastoma multiforme can originate from cortical neurons

Scientists have long believed that glioblastoma multiforme (GBM), the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. In a paper published October 18 in Science Express, however, researchers at the Salk Institute for Biological Studies have found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.

23 Oct 2012

John Theurer Cancer Center, LRF to host Ask the Doctor About Lymphoma

The Lymphoma Research Foundation (LRF), the nation's largest non-profit organization devoted to lymphoma research, is partnering with John Theurer Cancer Center, one of the nation's 50 best hospitals for cancer, to bring the lymphoma community information about the rapidly changing world of lymphoma treatment.

23 Oct 2012

Methylation provides clues to gastric cancer subtypes

Research published in Science Translational Medicine shows that many gastric cancers are associated with significant epigenetic alterations along the DNA triggered by methylation.

22 Oct 2012

Immediate postoperative radiation improves prostate cancer progression survival

Radiation immediately after prostate cancer surgery substantially improves biochemical progression-free survival and local control over 10 years compared with a wait-and-see policy, European study findings indicate.

22 Oct 2012

Multivitamin use may protect men from cancer

Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians’ Health Study II.

22 Oct 2012

Elderly female cancer survivors reap benefits of following prevention advice

Elderly female cancer survivors who adhere stringently to national and international recommendations for cancer prevention have a reduced risk for all-cause mortality compared with their peers who are less adherent, show US study results.

22 Oct 2012

Liquid version of breast cancer drug Tamoxifen launched in the US

Breast Cancer Awareness Month raises visibility and research dollars to address a disease that in the United States claims nearly 40,000 lives annually and affects approximately 240,000 people who each year are newly diagnosed. While the month's activities are important in the fight against breast cancer, they are not designed to directly improve the day-to-day management of the disease.

22 Oct 2012